A laboratory technician inspects filled vials of investigational coronavirus disorder (COVID-19) treatment medication remdesivir in a Gilead Sciences center in La Verne, California, March 11, 2020.Gilead Sciences Inc | ReutersPresident Donald Trump said Wednesday that the U.S. government is sending Texas hospitals 500 instances of antifungal medication remdesivir as coronavirus deaths from the Lone Star State hit record highs. The instances of this medication, made by Gilead Sciences, will probably be sufficient to deal with 3,200 patients, Trump said during a media briefing in Midland, Texas. The medication was “very, very powerful,” he added. On Tuesday, Texas reported 200 new deaths, hitting a record-high average. Texas is among 10 countries, such as Florida and California, which reported record-high average everyday new Covid-19 deaths on Tuesday, as determined by a average calculated by CNBC using information gathered by Johns Hopkins University. There are more than 9,500 patients hospitalized with Covid-19 across Texas’ hospitals, a 62% growth in a month ago, based on updated data in the Texas Department of State Health Services. Recently, hospitals across the U.S. have reported shortages of remdesivir. There are not any FDA-approved medications for your coronavirus. The intravenous drug has helped shorten the healing period of a hospitalized Covid-19 patients. In May, the FDA allowed remdesivir a emergency use authorization, enabling physicians and physicians to use the drug on patients hospitalized with the illness despite the fact that the medication hasn’t been officially accepted by the agency.The Department of Health and Human Services declared June 29 a bargain which provides the U.S. greater than 500,000 treatment courses of the antiviral drug for U.S. hospitals during September. That signifies 100% of Gilead’s projected manufacturing for July and 90% of production for August and September, according to the agency.The U.S. government collects information from hospitals around the amount of Covid-19 patients to ascertain just how much of the antifungal medication ought to be delivered to every condition or region.Gilead is promoting remdesivir for $520 each vial from the U.S. to patients with private insurance and $390 each vial to national insurance programs like Medicare in addition to foreign nations. Nearly all patients treated using remdesivir get a five-day treatment class with six vials of remdesivir, the business has said.